Molecular Docking and Drug-Likeness Profiling of Phytochemical from Murraya koenigii against Estrogen Receptor Alpha

Penambatan Molekuler dan Profil Drug-Likeness Senyawa Fitokimia dari Murraya koenigii terhadap Reseptor Estrogen Alfa

Authors

  • Yasmin Fathina Saputra Universitas Mulawarman Author
  • Muhammad Nahrawi Udharaja Research and Development Laboratory, PT. Borneo Riseta Naturafarm, Kutai Kertanegara, East Kalimantan, Indonesia Author
  • Viviana Idris UPTD Pusat Kesehatan Masyarakat (Puskesmas) Sidomulyo, Dinas Kesehatan Kota Samarinda, Samarinda, Kalimantan Timur, Indonesia Author
  • Iswahyudi Iswahyudi Research and Development Laboratory, PT. Borneo Riseta Naturafarm, Kutai Kertanegara, Kalimantan Timur, Indonesia Author

DOI:

https://doi.org/10.70392/jrn.v3i2.31

Keywords:

Murraya koenigii, Estrogen receptor alpha, Molecular Docking, Phytochemicals, Swiss-ADME, Drug-likeness

Abstract

Breast cancer remains a major health problem, particularly in estrogen receptor-positive disease in which estrogen receptor alpha (ER-α) is an important molecular target. Curry leaf (Murraya koenigii) contains diverse secondary metabolites with reported pharmacological activities, but the interaction of its phytochemicals with ER-α has not been comprehensively characterized in the present study framework. This study evaluated 20 phytochemicals from M. koenigii against ER-α using an in silico molecular docking approach. The ER-α structure (PDB ID: 3ERT) was prepared using AutoDock Tools, while test ligands were constructed and energy-minimized using MarvinSketch. Docking was performed with AutoDock4 using the validated grid parameters, and binding interactions were visualized with BIOVIA Discovery Studio Visualizer. The redocking validation produced an RMSD of 1.049 Å, supporting the applicability of the docking protocol. Eleven compounds showed binding energies approaching the reference ligand 4-hydroxytamoxifen; Murrayazoline (-10.68 kcal/mol) and Pyrayafoline D (-10.11 kcal/mol) showed the most favorable docking scores among the tested phytochemicals. Ten of the 11 selected compounds interacted with relevant ER-α binding-site residues, while Isomahanine did not directly interact with the key Glu353/Arg394 site. Swiss-ADME prediction further identified Koenimbine, O-Methylmurrayamine, and Koenine as the most favorable compounds in the combined drug-likeness assessment, although Koenine showed a saturation-related limitation. These findings provide an in silico basis for prioritizing M. koenigii phytochemicals for subsequent experimental validation.

References

Adebayo, K.S., Ajao, J.J., Oderemi, O.M., Ughagwu, K.P. Breast Cancer Therapies: A Review. Asia Pac. J. Cancer Biol. 2024, 9, 53–59. DOI: 10.31557/APJCB.2024.9.1.53.

Herawati, A., Rijal, S., Arsal, A.S., Purnamasari, R., Abdi, D.A., Wahid, S. Karakteristik Kanker Payudara. Fakumi Med. J. 2021, 1, 44–53.

Liu, Y., Ma, H., Yao, J. ERα, A Key Target for Cancer Therapy: A Review. OncoTargets Ther. 2020, 13, 2183–2191

Sharma, D., Kumar, S., Narasimhan, B. Estrogen alpha receptor antagonists for the treatment of breast cancer: a re-view. Chemistry Central Journal 2018, 12(1), 107.

Shiau, A.K., Barstad, D., Loria, P.M., Cheng, L., Kushner, P.J., Agard, D.A., Greene, G.L. The structural basis of estrogen re-ceptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95(7), 927-937.

Paterni, I., Granci, C., Katzenellenbogen, J.A., Minutolo, F. Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential. Steroids 2014, 90, 13–29.

Balakrishnan, R., Vijayraja, D., Jo, S.-H., Ganesan, P., Su-Kim, I., Choi, D.-K. Medicinal Profile, Phytochemistry, and Phar-macological Activities of Murraya koenigii and Its Primary Bioactive Compounds. Antioxidants 2020, 9, 101.

Singh, S., Ahuja, A., Murti, Y., Khaliq, A. Phyto-Pharmacological Review on Murraya koenigii (L.) Spreng: As an Indigenous Plant of India with High Medicinal Potential. Chem. Biodivers. 2023, 20, 1–20.

Sadwal, S., Bharati, S., Dar, Z.A., Kaur, S. Chemopreventive potential of hydroethanolic Murraya koenigii leaves extract against DMBA induced breast carcinogenesis: In-silico and in-vivo study. J. Ethnopharmacol. 2024, 319, 117–124.

Kumar, D., Sharma, P., Mahajan, A., Dhawan, R., Dua, K. Pharmaceutical interest of in-silico approaches. Phys. Sci. Rev. 2023, 8, 2547–2560.

Suhud, F. Uji Aktivitas In-silico Senyawa Baru 1-Benzil-3-benzoilurea Induk dan Tersubstitusi sebagai Agen Antiproliferatif. J. Farm. Indones. 2015, 7, 242–251.

Helgren, T.R., Hagen, T.J. Demonstration of AutoDock as an Educational Tool for Drug Discovery. J. Chem. Educ. 2017, 94, 345–349.

Khan, S.A., Wu, Y., Li, A.S.M., Fu, X.Q., Yu, Z.L. Network pharmacology and molecular docking-based prediction of active compounds and mechanisms of action of Cnidii Fructus in treating atopic dermatitis. BMC Complement. Med. Ther. 2022, 22, 275.

Puranik, N.V., Srivastava, P., Bhatt, G., John Mary, D.J.S., Limaye, A.M., Sivaraman, J. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular mod-elling approach. Scientific Reports 2019, 9(1), 7450. DOI: 10.1038/s41598-019-43768-5.

Dermawan, D., Sumirtanurdin, R., Dewantisari, D. Molecular dynamics simulation estrogen receptor alpha againts andro-grapholide as anti-breast cancer. Indonesian Journal of Pharmaceutical Science and Technology 2019, 6(2), 65-76.

Daina, A., Michielin, O., Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports 2017, 7, 42717.

Mohanty, M., Mohanty, P.S. Molecular docking in organic, inorganic, and hybrid systems: A tutorial review. Monatshefte Chem. 2023, 154, 683–707. DOI: 10.1007/s00706-023-03076-1.

Alam, P., Sharma, P., Arshad, M.F. Comprehensive Computational Screening and Analysis of Natural Compounds Reveals Promising Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy. Chem. Biodivers. 2025, 22, e202402052. DOI: 10.1002/cbdv.202402052.

Arifian, H., Maharani, R., Megantara, S., Ikram, N.K.K., Muchtaridi. Glycine-Conjugated α-Mangostins as Potential Estrogen Receptor Alpha (ERα) Antagonists through Pharmacophore Modeling, Docking Analysis, and Molecular Dynamics Simulations. Appl. Sci. 2024, 14, 5549. DOI: 10.3390/app14135549.

Ancuceanu, R., Lascu, B.E., Drăgănescu, D., Dinu, M. In Silico ADME Methods Used in the Evaluation of Natural Products. Pharmaceutics 2025, 17, 1002. DOI: 10.3390/pharmaceutics17081002.

Samanta, S. K., Choudhury, P., Kandimalla, R., Aqil, F., Moholkar, D.N., Gupta, R.C., Das, M., Gogoi, B., Gogoi, N., Sar-ma, P.P., Devi, R., Talukdar, N.C. Mahanine mediated therapeutic inhibition of estrogen receptor-α and CDK4/6 expression, decipher the chemoprevention-signaling cascade in preclinical model of breast cancer. Journal of Ethnopharmacology 2024, 319, 117235.

Chan, E.W.C., Wong, S.K. Constituents of carbazole alkaloids and anti-cancer properties of extracts, mahanine, isomahanine, mahanimbine, and girinimbine from Bergera koenigii. J. Appl. Pharm. Sci. 2024, 14(10), 25–34. DOI: 10.7324/JAPS.2024.192931

Bose, D., Shetty, S., Udupi, A., Srinivasan, K. Murraya koenigii as a phytotherapeutic agent in breast cancer: A comprehensive review. Pharmacol. Res. Nat. Prod. 2025, 10, 100487. DOI: 10.1016/j.prenap.2025.100487.

Bake, M.M., Fofack, H.M.T., Abdelli, W., Ntie-Kang, F., Berga, G., Ndassa, I.M., Vercauteren, D.P., Mohammad-Salim, H.A., Vicente De Julian-Ortiz, J. Unlocking potential natural products from African sources targeting overexpressed estrogen receptor alpha (ERα) in breast cancer: In silico studies. Comput. Struct. Biotechnol. Rep. 2025, 2, 100033. DOI: 10.1016/j.csbr.2025.100033.

Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001, 46(1-3), 3-26. https://doi.org/10.1016/S0169-409X(00)00129-0

Daina, A., Zoete, V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 2016, 11(11), 1117-1121. https://doi.org/10.1002/cmdc.201600182

Tan, S.P., Nishigaki, T., Ito, C. Carbazole alkaloids and their biological activities. Natural Product Communications 2014, 9(2), 273-288.

Downloads

Published

13-11-2026

How to Cite

Saputra, Y. F., Udharaja, M. N., Idris, V. ., & Iswahyudi, I. (2026). Molecular Docking and Drug-Likeness Profiling of Phytochemical from Murraya koenigii against Estrogen Receptor Alpha: Penambatan Molekuler dan Profil Drug-Likeness Senyawa Fitokimia dari Murraya koenigii terhadap Reseptor Estrogen Alfa. Jurnal Riseta Naturafarm, 3(2), 78-89. https://doi.org/10.70392/jrn.v3i2.31